Metabolic Brain Disease

, Volume 29, Issue 4, pp 991–1006 | Cite as

α-Ketoglutaramate: an overlooked metabolite of glutamine and a biomarker for hepatic encephalopathy and inborn errors of the urea cycle

Original Paper


Glutamine metabolism is generally regarded as proceeding via glutaminase-catalyzed hydrolysis to glutamate and ammonia, followed by conversion of glutamate to α-ketoglutarate catalyzed by glutamate dehydrogenase or by a glutamate-linked aminotransferase (transaminase). However, another pathway exists for the conversion of glutamine to α-ketoglutarate that is often overlooked, but is widely distributed in nature. This pathway, referred to as the glutaminase II pathway, consists of a glutamine transaminase coupled to ω-amidase. Transamination of glutamine results in formation of the corresponding α-keto acid, namely, α-ketoglutaramate (KGM). KGM is hydrolyzed by ω-amidase to α-ketoglutarate and ammonia. The net glutaminase II reaction is: L ‐ Glutamine + α ‐ keto acid + H2O → α ‐ ketoglutarate + L ‐ amino acid + ammonia. In this mini-review the biochemical importance of the glutaminase II pathway is summarized, with emphasis on the key component KGM. Forty years ago it was noted that the concentration of KGM is increased in the cerebrospinal fluid (CSF) of patients with hepatic encephalopathy (HE) and that the level of KGM in the CSF correlates well with the degree of encephalopathy. In more recent work, we have shown that KGM is markedly elevated in the urine of patients with inborn errors of the urea cycle. It is suggested that KGM may be a useful biomarker for many hyperammonemic diseases including hepatic encephalopathy, inborn errors of the urea cycle, citrin deficiency and lysinuric protein intolerance.


ω-Amidase Ammonia Glutaminase II Hepatic encephalopathy α-ketoglutaramate Urea cycle disorders 





Argininosuccinate synthase


Branched-chain amino acid aminotransferase


Cerebrospinal fluid


Carbamyl phosphate synthetase I


Gas chromatography-mass spectrometry




Glutamine transaminase K


Glutamine transaminase L


Hepatic encephalopathy


Kynurenine aminotransferase


Kidney type glutaminase






Liver type glutaminase


Lysinuric protein intolerance




Neonatal intrahepatic cholestasis

Nit 1

Nitrilase-like protein 1

Nit 2

Nitrilase-like protein 2


Phosphate-activated glutaminase


Ornithine transcarbamylase



Some of the author’s work mentioned in this review was supported by NIH grant DK 16739.

Conflict of interest

No potential conflict of interest relevant to this article is presented.


  1. Albuquerque EX, Schwarcz R (2013) Kynurenic acid as an antagonist of α7 nicotinic acetylcholine receptors in the brain: facts and challenges. Biochem Pharmacol 85:1027–1032PubMedCentralPubMedGoogle Scholar
  2. Abou-Khalil WH, Yunis AA, Abou-Khalil S (1983) Prominent glutamine oxidation activity in mitochondria of hematopoietic tumors. Cancer Res 43:1990–1993PubMedGoogle Scholar
  3. Barglow KT, Saikatendu KS, Bracey MH, Huey R, Morris GM, Olson AJ, Stevens RC, Cravatt BF (2008) Functional proteomic and structural insights into molecular recognition in the nitrilase family enzymes. Biochemistry 47:13514–13523PubMedCentralPubMedGoogle Scholar
  4. Beal MF, Swartz KJ, Isacson O (1992) Developmental changes in brain kynurenic acid concentrations. Brain Res Dev Brain Res 68:136–139PubMedGoogle Scholar
  5. Bergmeyer U (ed) (1974) Methods of Enzymatic analysis. 2nd English edn. Verlag ChemieWeiheim, Academic Press, New York, p 2285Google Scholar
  6. Bourke E, Fine A, Scott J (1971a) Mechanism of ammoniagenesis in human kidney. Biochem J 125(4):94PPubMedCentralPubMedGoogle Scholar
  7. Bourke E, Fine A, Scott JM (1971b) Glutaminase II pathway in human kidney. Nat New Biol 233:249–250PubMedGoogle Scholar
  8. Bourke E, Frindt G, Rubio-Paez D, Schreiner GE (1971c) Effect of chronic alkalosis and acidosis on glutaminase II path in the dog kidney in vivo. Am J Physiol 220:1033–1036PubMedGoogle Scholar
  9. Brennan RW, Plum F (1971) A cerebrospinal fluid transfer model for hepatic and uremic encephalopathy. Trans Am Neurol Assoc 96:210–211PubMedGoogle Scholar
  10. Bröer S, Palacín M (2011) The role of amino acid transporters in inherited and acquired diseases. Biochem J 436:193–211PubMedGoogle Scholar
  11. Brusilow SW, Horwich AL (2001) Urea cycle enzymes Chapter 85. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New YorkGoogle Scholar
  12. Brusilow SW, Cooper AJL (2011) Encephalopathy in acute liver failure resulting from acetaminophen intoxication: new observations with potential therapy. Crit Care Med 39:2550–2553PubMedCentralPubMedGoogle Scholar
  13. Brusilow SW, Koehler RC, Traystman RJ, Cooper AJL (2010) Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics 7:452–470PubMedCentralPubMedGoogle Scholar
  14. Buchli R, Alberati-Giani D, Malherbe P, Köhler C, Broger C, Cesura AM (1995) Cloning and functional expression of a soluble form of kynurenine/α-aminoadipate aminotransferase from rat kidney. J Biol Chem 270:29330–29335PubMedGoogle Scholar
  15. Butterworth RF (2013) The liver-brain axis in liver failure: neuroinflammation and encephalopathy. Nat Rev Gastroenterol Hepatol 10:522–528PubMedGoogle Scholar
  16. Cassago A, Ferreira AP, Ferreira IM, Fornezari C, Gomes ER, Greene KS, Pereira HM, Garratt RC, Dias SM, Ambrosio AL (2012) Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism. Proc Natl Acad Sci U S A 109:1092–1097PubMedCentralPubMedGoogle Scholar
  17. Cathelineau L, Briand P, Ogier H, Charpentier C, Coude FX, Saudubray JM (1981) Occurrence of hyperammonemia in the course of 17 cases of methylmalonic acidemia. J Pediatr 99:279–280PubMedGoogle Scholar
  18. Chavarria L, Alonso J, García-Martínez R, Simón-Talero M, Ventura-Cots M, Ramírez C, Torrens M, Vargas V, Rovira A, Córdoba J (2013) Brain magnetic resonance spectroscopy in episodic hepatic encephalopathy. J Cereb Blood Flow Metab 33:272–277PubMedCentralPubMedGoogle Scholar
  19. Chien CH, Gao QZ, Cooper AJL, Lyu JH, Sheu SY (2012) Structural insights into the catalytic active site and activity of human Nit2/ω-amidase: kinetic assay and molecular dynamics simulation. J Biol Chem 287:25715–25726PubMedCentralPubMedGoogle Scholar
  20. Chow KW, Walser M (1974) Substitution of five essential amino acids by their alpha-keto analogues in the diet of rats. J Nutr 104:1208–1214PubMedGoogle Scholar
  21. Cooper AJL (1988) Glutamine aminotransferases and ω-amidases. In: Kvamme E (ed) Glutamine and glutamate in mammals, vol 1. CRC Press, Inc, Boca Raton, pp 33–52Google Scholar
  22. Cooper AJL (2004) The role of glutamine transaminase K (GTK) in sulfur and α-keto acid metabolism in the brain, and possible bioactivation of neurotoxicants. Neurochem Int 44:557–577PubMedGoogle Scholar
  23. Cooper AJL (2013) Possible treatment of end-stage hyperammonemic encephalopathy by inhibition of glutamine synthetase. Metab Brain Dis 28:119–125PubMedGoogle Scholar
  24. Cooper AJL, Gross M (1977) The glutamine transaminase-ω-amidase system in rat and human brain. J Neurochem 28:771–778PubMedGoogle Scholar
  25. Cooper AJL, Meister A (1972) Isolation and properties of highly purified glutamine transaminase. Biochemistry 11:661–671PubMedGoogle Scholar
  26. Cooper AJL, Meister A (1974) Isolation and properties of a new glutamine transaminase from rat kidney. J Biol Chem 249:2554–2561PubMedGoogle Scholar
  27. Cooper AJL, Meister A (1977) The glutamine transaminase - ω-amidase pathway. CRC Crit Rev Biochem 4:281–303PubMedGoogle Scholar
  28. Cooper AJL, Meister A (1981) Comparative studies of glutamine transaminases from rat tissues. Comp Biochem Physiol 69B:137–145Google Scholar
  29. Cooper AJL, Plum F (1987) Biochemistry and physiology of brain ammonia. Physiol Rev 67:440–519PubMedGoogle Scholar
  30. Cooper AJL, Dhar AK, Kutt H, Duffy TE (1980) Determination of 2-pyrrolidone-5-carboxylic and α-ketoglutaramic acids in human cerebrospinal fluid by gas chromatography. Anal Biochem 103:118–126PubMedGoogle Scholar
  31. Cooper AJL, Duffy TE, Meister A (1985) α-Keto acid ω-amidase from rat liver. Methods Enzymol 113:350–358PubMedGoogle Scholar
  32. Cooper AJL, Abraham DG, Gelbard AS, Lai JC, Petito CK (1993) High activities of glutamine transaminase K (dichlorovinylcysteine β-lyase) and ω-amidase in the choroid plexus of rat brain. J Neurochem 61:1731–1741PubMedGoogle Scholar
  33. Cooper AJL, Krasnikov BF, Niatsetskaya ZV, Pinto JT, Callery PS, Villar MT, Artigues A, Bruschi SA (2011) Cysteine S-conjugate β-lyases: important roles in the metabolism of naturally occurring sulfur and selenium-containing compounds, xenobiotics and anticancer agents. Amino Acids 41:7–27PubMedCentralPubMedGoogle Scholar
  34. Cooper AJL, Dorai T, Dorai B, Krasnikov BF, Li J, Hallen A, Pinto JT (2013) Role of Glutamine transaminases in nitrogen, sulfur, selenium and 1-carbon metabolism. In: Rajendram R, Preedy VR, Patel VB (eds) Glutamine in health and disease. Springer, New York, in pressGoogle Scholar
  35. Cudalbu C, Lanz B, Duarte JM, Morgenthaler FD, Pilloud Y, Mlynárik V, Gruetter R (2012) Cerebral glutamine metabolism under hyperammonemia determined in vivo by localized 1H and 15N NMR spectroscopy. J Cereb Blood Flow Metab 32:696–708PubMedCentralPubMedGoogle Scholar
  36. Dai Y, Wensink PC, Abeles RH (1999) One protein, two enzymes. J Biol Chem 274:1193–1195PubMedGoogle Scholar
  37. Dai Y, Pochapsky TC, Abeles RH (2001) Mechanistic studies of two dioxygenases in the methionine salvage pathway of Klebsiella pneumoniae. Biochemistry 40:6379–6387PubMedGoogle Scholar
  38. Darmaun D, Matthews DE, Bier DM (1986) Glutamine and glutamate kinetics in humans. Am J Physiol 251:E117–E126PubMedGoogle Scholar
  39. Desjardins P, Du T, Jiang W, Peng L, Butterworth RF (2012) Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure: role of glutamine redefined. Neurochem Int 60:690–696PubMedGoogle Scholar
  40. Duffy TE, Cooper AJL, Meister A (1974a) Identification of α-ketoglutaramate in rat liver, kidney, and brain. Relationship to glutamine transaminase and ω-amidase activities. J Biol Chem 249:7603–7606PubMedGoogle Scholar
  41. Duffy TE, Vergara F, Plum F (1974b) α-Ketoglutaramate in hepatic encephalopathy. Res Publ Assoc Res Nerv Ment Dis 53:39–52PubMedGoogle Scholar
  42. Durán RV, Oppliger W, Robitaille AM, Heiserich L, Skendaj R, Gottlieb E, Hall MN (2012) Glutaminolysis activates Rag-mTORC1 signaling. Mol Cell 47:349–358PubMedGoogle Scholar
  43. Erickson JW, Cerione RA (2010) Glutaminase: a hot spot for regulation of cancer cell metabolism? Oncotarget 1:734–740PubMedCentralPubMedGoogle Scholar
  44. Errera M, Greenstein JP (1949) Phosphate-activated glutaminase in kidney and other tissues. J Biol Chem 178:495–502PubMedGoogle Scholar
  45. Filipowicz HR, Ernst SL, Ashurst CL, Pasquali M, Longo N (2006) Metabolic changes associated with hyperammonemia in patients with propionic acidemia. Mol Genet Metab 88:123–130PubMedGoogle Scholar
  46. Greenstein JP, Price VE (1949) α-Keto acid-activated glutaminase and asparaginase. J Biol Chem 178:695–705PubMedGoogle Scholar
  47. Guidetti P, Amori L, Sapko MT, Okuno E, Schwarcz R (2007) Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain. J Neurochem 102:103–111PubMedGoogle Scholar
  48. Halámková L, Mailloux S, Halámek J, Cooper AJ, Katz E (2012) Enzymatic analysis of α-ketoglutaramate - a biomarker for hyperammonemia. Talanta 100:7–11PubMedGoogle Scholar
  49. Han Q, Li J, Li J (2004) pH dependence, substrate specificity and inhibition of human kynurenine aminotransferase I. Eur J Biochem 71:4804–4814Google Scholar
  50. Han Q, Cai T, Tagle DA, Robinson H, Li J (2008) Substrate specificity and structure of human aminoadipate aminotransferase/kynurenine aminotransferase II. Biosci Rep 28:205–215PubMedCentralPubMedGoogle Scholar
  51. Han Q, Robinson H, Cai T, Tagle DA, Li J (2009) Biochemical and structural properties of mouse kynurenine aminotransferase III. Mol. Cell Biol 29:784–793Google Scholar
  52. Häussinger D, Stehle T, Gerok W (1985) Glutamine metabolism in isolated perfused rat liver. The transamination pathway. Biol Chem Hoppe Seyler 366:527–536PubMedGoogle Scholar
  53. Heidelberger C, Gullberg ME, Morgan AF, Lepkovsky S (1949) Tryptophan metabolism; concerning the mechanism of the mammalian conversion of tryptophan into kynurenine, kynurenic acid, and nicotinic acid. J Biol Chem 179:143–150PubMedGoogle Scholar
  54. Heins J, Zwingmann C (2010) Organic osmolytes in hyponatremia and ammonia toxicity. Metab Brain Dis 25:81–89PubMedGoogle Scholar
  55. Herlong HF, Maddrey WC, Walser M (1980) The use of ornithine salts of branched-chain ketoacids in portal-systemic encephalopathy. Ann Intern Med 93:545–550PubMedGoogle Scholar
  56. Hersh LB (1971) Rat liver ω-amidase: purification and properties. Biochemistry 10:2884–2891PubMedGoogle Scholar
  57. Hersh LB (1972) Rat liver ω-amidase. Kinetic evidence for an acyl-enzyme intermediate. Biochemistry 11:2251–2256PubMedGoogle Scholar
  58. Hoffer LJ, Taveroff A, Robitaille L, Mamer OA, Reimer ML (1993) α-Keto and α-hydroxy branched-chain acid interrelationships in normal humans. J Nutr 123:1513–1521PubMedGoogle Scholar
  59. Holecek M (2013) Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectives. Metab Brain DisGoogle Scholar
  60. Huebner K, Saldivar JC, Sun J, Shibata H, Druck T (2011) Hits, Fhits and Nits: beyond enzymatic function. Adv Enzyme Regul 51:208–217PubMedCentralPubMedGoogle Scholar
  61. Hutson SM, Harper AE (1981) Blood and tissue branched-chain amino and α-keto acid concentrations: effect of diet, starvation, and disease. Am J Clin Nutr 34:173–183Google Scholar
  62. Hutson SM, Rannels SL (1985) Characterization of a mitochondrial transport system for branched chain α-keto acids. J Biol Chem 260:14189–14193PubMedGoogle Scholar
  63. Jaisson S, Veiga-da-Cunha M, Van Schaftingen E (2009) Molecular identification of ω-amidase, the enzyme that is functionally coupled with glutamine transaminases, as the putative tumor suppressor Nit2. Biochimie 91:1066–1071PubMedGoogle Scholar
  64. Jones TW, Qin C, Schaeffer VH, Stevens JL (1988) Immunohistochemical localization of glutamine transaminase K, a rat kidney cysteine conjugate β-lyase, and the relationship to the segment specificity of cysteine conjugate nephrotoxicity. Mol Pharmacol 34:621–627PubMedGoogle Scholar
  65. Keiding S, Pavese N (2013) Brain metabolism in patients with hepatic encephalopathy studied by PET and MR. Arch Biochem Biophys 536:131–142PubMedGoogle Scholar
  66. Kim HS, Cha SH, Abraham DG, Cooper AJL, Endou H (1997) Intranephron distribution of cysteine S-conjugate beta-lyase activity and its implication for hexachloro-1,3-butadiene-induced nephrotoxicity in rats. Arch Toxicol 71:131–141PubMedGoogle Scholar
  67. Koppenol WH, Bounds PL, Dang CV (2011) Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer 11:325–337PubMedGoogle Scholar
  68. Krasnikov BF, Chien C-H, Nostramo R, Pinto JT, Nieves E, Callaway M, Sun J, Huebner K, Cooper AJL (2009) Identification of the putative tumor suppressor Nit2 as ω-amidase, an enzyme metabolically linked to glutamine and asparagine transamination. Biochimie 91:1072–1080PubMedCentralPubMedGoogle Scholar
  69. Kuhara T (2007) Noninvasive human metabolome analysis for differential diagnosis of inborn errors of metabolism. J Chromatogr B Anal Technol Biomed Life Sci 855:42–50Google Scholar
  70. Kuhara T, Ohse M, Inoue Y, Cooper AJL (2011a) A GC/MS-based metabolomic approach for diagnosing citrin deficiency. Anal Bioanal Chem 400:1881–1894PubMedGoogle Scholar
  71. Kuhara T, Inoue Y, Ohse M, Krasnikov BF, Cooper AJL (2011b) Urinary 2-hydroxy-5-oxoproline, the lactam form of α-ketoglutaramate, is markedly increased in urea cycle disorders. Anal Bioanal Chem 400:1843–1851PubMedCentralPubMedGoogle Scholar
  72. Lavoie J, Giguère JF, Layrargues GP, Butterworth RF (1987) Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. J Neurochem 49:692–697PubMedGoogle Scholar
  73. Lin CH, Chung MY, Chen WB, Chien CH (2007) Growth inhibitory effect of the human NIT2 gene and its allelic imbalance in cancers. FEBS J 274:2946–2956PubMedGoogle Scholar
  74. Linster CL, Van Schaftingen E, Hanson AD (2013) Metabolite damage and its repair or pre-emption. Nat Chem Biol 9:72–80PubMedGoogle Scholar
  75. Lockwood AH, Duffy TE (1977) Glutamine transaminase and ω-amidase: species variations in brain activity and effect of portacaval shunting. J Neurochem 28:673–675PubMedGoogle Scholar
  76. Maddrey WC, Weber FL Jr, Coulter AW, Chura CM, Chapanis NP, Walser M (1976) Effects of keto analogues of essential amino acids in portal-systemic encephalopathy. Gastroenterology 71:190–195PubMedGoogle Scholar
  77. Malherbe P, Alberati-Giani D, Köhler C, Cesura AM (1995) Identification of a mitochondrial form of kynurenine aminotransferase/glutamine transaminase K from rat brain. FEBS Lett 367:141–144PubMedGoogle Scholar
  78. Mallet RT, Kelleher JK, Jackson MJ (1986) Substrate metabolism of isolated jejunal epithelium: conservation of three-carbon units. Am J Physiol 250:C191–C198PubMedGoogle Scholar
  79. Martinez-Hernandez A, Bell KP, Norenberg MD (1977) Glutamine synthetase: glial localization in brain. Science 195:1356–1358PubMedGoogle Scholar
  80. Mardini H, Smith FE, Record CO, Blamire AM (2011) Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia. J Hepatol 54:1154–1160PubMedGoogle Scholar
  81. Meister A (1953) Preparation and enzymatic reactions of the keto analogues of glutamine and asparagine. J Biol Chem 200:571–589PubMedGoogle Scholar
  82. Meister A, Sober HA, Tice SV, Fraser PE (1952) Transamination and associated deamidation of asparagine and glutamine. J Biol Chem 197:319–330PubMedGoogle Scholar
  83. Meister A, Levintow L, Greenfield RE, Abendschein PA (1955) Hydrolysis and transfer reactions catalyzed by ω-amidase. J Biol Chem 215:441–460PubMedGoogle Scholar
  84. Mena FV, Baab PJ, Zielke CL, Huang Y, Zielke HR (2005) Formation of extracellular glutamate from glutamine: exclusion of pyroglutamate as an intermediate. Brain Res 1052:88–96PubMedGoogle Scholar
  85. Miller JE, Litwack G (1971) Purification, properties, and identity of liver mitochondrial tyrosine aminotransferase. J Biol Chem 246:3234–3240PubMedGoogle Scholar
  86. Mosca M, Cozzi L, Breton J, Speciale C, Okuno E, Schwarcz R, Benatti L (1994) Molecular cloning of rat kynurenine aminotransferase: identity with glutamine transaminase K. FEBS Lett 353:21–24PubMedGoogle Scholar
  87. Nissim I, Wehrli S, States B, Nissim I, Yudkoff M (1991) Analysis and physiological implications of renal 2-oxoglutaramate metabolism. Biochem J 277:33–38PubMedCentralPubMedGoogle Scholar
  88. Norenberg MD, Martinez-Hernandez A (1979) Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 161:303–310PubMedGoogle Scholar
  89. Notarangelo FM, Wu HQ, Macherone A, Graham DR, Schwarcz R (2012) Gas chromatography/tandem mass spectrometry detection of extracellular kynurenine and related metabolites in normal and lesioned rat brain. Anal Biochem 421:573–581PubMedCentralPubMedGoogle Scholar
  90. Ogier de Baulny H, Schiff M, Dionisi-Vici C (2012) Lysinuric protein intolerance (LPI): a multi organ disease by far more complex than a classic urea cycle disorder. Mol Genet Metab 106:12–17PubMedGoogle Scholar
  91. Okuno E, Nakamura M, Schwarcz R (1991) Two kynurenine aminotransferases in human brain. Brain Res 542:307–312PubMedGoogle Scholar
  92. Olson KC, Chen G, Lynch CJ (2013) Quantification of branched-chain keto acids in tissue by ultra fast liquid chromatography-mass spectrometry. Anal Biochem 439:116–122PubMedGoogle Scholar
  93. Otani TT, Meister A (1957) ω-Amide and ω-amino acid derivatives of α-ketoglutaric and oxalacetic acids. J Biol Chem 224:137–148PubMedGoogle Scholar
  94. Pace HC, Brenner C (2001) The nitrilase superfamily: classification, structure and function. Genome Biol 2(1)Google Scholar
  95. Pailla K, Blonde-Cynober F, Aussel C, De Bandt JP, Cynober L (2000) Branched-chain keto-acids and pyruvate in blood: measurement by HPLC with fluorimetric detection and changes in older subjects. Clin Chem 46:848–853PubMedGoogle Scholar
  96. Pamiljans V, Krishnaswamy PR, Dumville G, Meister A (1962) Studies on the mechanism of glutamine synthesis; isolation and properties of the enzyme from sheep brain. Biochemistry 1:153–158PubMedGoogle Scholar
  97. Patel TB, Waymack PP, Olson MS (1980) The effect of the monocarboxylate translocator inhibitor, α-cyanocinnamate, on the oxidation of branched chain α-keto acids in rat liver. Arch Biochem Biophys 201:629–635PubMedGoogle Scholar
  98. Pawlak D, Tankiewicz A, Matys T, Buczko W (2003) Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure. J Physiol Pharmacol 54:175–189PubMedGoogle Scholar
  99. Perry SJ, Schofield MA, MacFarlane M, Lock EA, King LJ, Gibson GG, Goldfarb PS (1993) Isolation and expression of a cDNA coding for rat kidney cytosolic cysteine conjugate β-lyase. Mol Pharmacol 43:660–665PubMedGoogle Scholar
  100. Perry S, Harries H, Scholfield C, Lock T, King L, Gibson G, Goldfarb P (1995) Molecular cloning and expression of a cDNA for human kidney cysteine conjugate β-lyase. FEBS Lett 360:277–280PubMedGoogle Scholar
  101. Plum F (1971) The CSF in hepatic encephalopathy. Exp Biol Med 4:34–41PubMedGoogle Scholar
  102. Polet F, Feron O (2013) Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force. J Intern Med 273:156–165PubMedGoogle Scholar
  103. Porter LD, Ibrahim H, Taylor L, Curthoys NP (2002) Complexity and species variation of the kidney-type glutaminase gene. Physiol Genomics 9:157–166PubMedGoogle Scholar
  104. Record CO, Buxton B, Chase RA, Curzon G, Murray-Lyon IM, Williams R (1976) Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest 6:387–394PubMedGoogle Scholar
  105. Roediger WE (1982) Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83:424–429PubMedGoogle Scholar
  106. Sahai A, Nissim I, Tannen RL (1991) Pathways of acute pH regulation of ammoniagenesis in LLC-PK1 cells: study with [15N]glutamine. Am J Physiol 261:F481–F487PubMedGoogle Scholar
  107. Saheki T, Kobayashi K (2002) Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J Hum Genet 47:333–341PubMedGoogle Scholar
  108. Sapir DG, Owen OE, Pozefsky T, Walser M (1974) Nitrogen sparing induced by a mixture of essential amino acids given chiefly as their keto-analogues during prolonged starvation in obese subjects. J Clin Invest 54:974–980PubMedCentralPubMedGoogle Scholar
  109. Scholl-Bürgi S, Sass JO, Zschocke J, Karall D (2012) Amino acid metabolism in patients with propionic acidaemia. J Inherit Metab Dis 35:65–70PubMedGoogle Scholar
  110. Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13:465–477PubMedCentralPubMedGoogle Scholar
  111. Shrawder E, Martinez-Carrion M (1972) Evidence of phenylalanine transaminase activity in the isoenzymes of aspartate transaminase. J Biol Chem 247:2486–2492PubMedGoogle Scholar
  112. Siguira M (1957) A pharmacological aspect on glutamic acid metabolism in brain: transamination and associated deamidation of glutamine to α-keto acid in brain. Jpn J Pharmacol 7:1–5Google Scholar
  113. Stegink LD, Filer LJ Jr, Brummel MC, Baker GL, Krause WL, Bell EF, Ziegler EE (1991) Plasma amino acid concentrations and amino acid ratios in normal adults and adults heterozygous for phenylketonuria ingesting a hamburger and milk shake meal. Am J Clin Nutr 53:670–675PubMedGoogle Scholar
  114. Steele RD (1986) Blood–brain barrier transport of the α-keto acid analogs of amino acids. Fed Proc 45:2060–2064PubMedGoogle Scholar
  115. Sweatt AJ, Wood M, Suryawan A, Wallin R, Willingham MC, Hutson SM (2004) Branched-chain amino acid catabolism: unique segregation of pathway enzymes in organ systems and peripheral nerves. Am J Physiol Endocrinol Metab 286:E64–E76PubMedGoogle Scholar
  116. Van Leuven F (1975) Highly purified glutamine transaminase from rat brain. Physical and kinetic properties. Eur J Biochem 58:153–158PubMedGoogle Scholar
  117. Van Leuven F (1976) Glutamine transaminase from brain tissue. Further studies on kinetic properties and specificity of the enzyme. Eur J Biochem 65:271–274PubMedGoogle Scholar
  118. Van Schaftingen E, Rzem R, Marbaix A, Collard F, Veiga-da-Cunha M, Linster CL (2013) Metabolite proofreading, a neglected aspect of intermediary metabolism. J Inherit Metab Dis 36:427–434PubMedGoogle Scholar
  119. Vergara F, Plum F, Duffy TE (1974) α-Ketoglutaramate: increased concentrations in the cerebrospinal fluid of patients in hepatic coma. Science 183:81–83PubMedGoogle Scholar
  120. Walser M, Williamson JR (eds) (1981) Metabolism and clinical implications of branched chain amino and ketoacids. Elsevier, North HollandGoogle Scholar
  121. Walser M, Lund P, Ruderman NB, Coulter AW (1973) Synthesis of essential amino acids from their α-keto analogues by perfused rat liver and muscle. J Clin Invest 52:2865–2877PubMedCentralPubMedGoogle Scholar
  122. Walker S, Götz R, Czygan P, Stiehl A, Lanzinger G, Sieg A, Raedsch R, Kommerell B (1982) Oral keto analogs of branched-chain amino acids in hyperammonemia in patients with cirrhosis of the liver. A double-blind crossover study. Digestion 24:105–111PubMedGoogle Scholar
  123. Ward PS, Thompson CB (2012) Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 21:297–308PubMedCentralPubMedGoogle Scholar
  124. Wipf D, Ludewig U, Tegeder M, Rentsch D, Koch W, Frommer WB (2002) Conservation of amino acid transporters in fungi, plants and animals. Trends Biochem Sci 27:139–147PubMedGoogle Scholar
  125. Wray JW, Abeles RH (1995) The methionine salvage pathway in Klebsiella pneumoniae and rat liver. Identification and characterization of two novel dioxygenases. J Biol Chem 270:3147–3153PubMedGoogle Scholar
  126. Yoshida T (1967) Purification and some properties of soluble and mitochondrial glutamine-ketoacids transaminase isozymes. Vitamins 35:227–234, JapaneseGoogle Scholar
  127. Zheng X, Kang A, Dai C, Liang Y, Xie T, Xie L, Peng Y, Wang G, Hao H (2012) Quantitative analysis of neurochemical panel in rat brain and plasma by liquid chromatography-tandem mass spectrometry. Anal Chem 84:10044–10051PubMedGoogle Scholar
  128. Zielke HR, Ozand PT, Tildon JT, Sevdalian DA, Cornblath M (1978) Reciprocal regulation of glucose and glutamine utilization by cultured human diploid fibroblasts. J Cell Physiol 95:41–48PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Biochemistry and Molecular BiologyNew York Medical CollegeValhallaUSA
  2. 2.Department of Biochemistry, Division of Human Genetics, Medical Research InstituteKanazawa Medical UniversityKahoku-gunJapan
  3. 3.Japan Clinical Metabolomics InstituteKahokuJapan

Personalised recommendations